MUSC Catalyst News

Omicron variant now accounts for 97% of all cases sequenced by MUSC. Scientists are watching for signal that biggest surge of pandemic is at turning point.

Blood collection organizations have warned that blood supplies are alarmingly low and are urging donations.

Four Hollings researchers received grants from the American Cancer Society to support their work on promising projects.

After battling prostate cancer twice, Friedrich Andreas is sharing his story with others in hopes of raising awareness.

Supporters of national nonprofit Vision To Learn were on hand to cheer on Stono Park students receiving eyeglasses.

“We’ve already gone higher than I thought we might,” says scientist tracking COVID at MUSC as Omicron causes case numbers to explode.

Percentages are for the cool kids these days. We talk with Dr. Danielle Scheurer about all-things COVID.

MUSC Children's Health contributes to study showing vaccination is effective against MIS-C.

Newly approved treatments and more cervical cancer clinical trials on the horizon have Hollings doctors optimistic.

MUSC research team has identified a pathway by which a known antifibrotic protein works, providing a possible clinical solution for patients with fibrosis.